Publication | Open Access
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models
65
Citations
38
References
2021
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1